Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 3, 2012, Pages 397-403

  Rakowski, Tomasz ^a   Siudak, Zbigniew ^a   Dziewierz, Artur ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Angioplasty; Myocardial infarction; Risk factors; Smoking

Indexed keywords

ADULT; AGED; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; VASCULAR DISEASE;

AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; SEX FACTORS; SMOKING; SMOKING CESSATION; SURVIVAL RATE;

EID: 84868493023     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0764-0     Document Type: Article

References (22)

1. Doll R, Peto R (1976) Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 2:1525-1536
2. Wilhelmsson C, Vedin JA, Elmfeldt D et al (1975) Smoking and myocardial infarction. Lancet 1:415-420
3. Kannel WB, Higgins M (1990) Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl 8:S3-S8
4. Barbash GI, White HD, Modan M et al (1993) Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 87:53-58
5. Barbash GI, Reiner J, White HD et al (1995) Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 26:1222-1229
6. Gourlay SG, Rundle AC, Barron HV (2002) Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). Nicotine Tob Res 4:101-107
7. Dudek D, Siudak Z, Janzon M et al (2008) European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab - EUROTRANSFER Registry. Am Heart J 156:1147-1154
8. Rakowski T, Siudak Z, Dziewierz A et al (2009) Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry. Am Heart J 158:569-575
9. Siudak Z, Rakowski T, Dziewierz A et al (2010) Early abciximab use in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention improves long-term outcome. Data from EUROTRANSFER Registry. Kardiol Pol 68:539-543
10. Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031-2037
11. Maggioni AP, Piantadosi F, Tognoni G et al (1998) Smoking is not a protective factor for patients with acute myocardial infarction: the viewpoint of the GISSI-2 Study. G Ital Cardiol 28:970-978
12. Schatzkin A, Cupples LA, Heeren T et al (1984) Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. Am J Epidemiol 120:888-899
13. Gomez MA, Karagounis LA, Allen A et al (1993) Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction. Am J Cardiol 72:373-378
14. Yip HK, Chen MC, Chang HW et al (2002) Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 122:1322-1332
15. Gibson CM, Murphy S, Menown IB et al (1999) Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 34:1403-1412
16. Rakowski T, Dziewierz A, Siudak Z et al (2011) Predictors of infarct-related artery patency following combined lytic therapy in patients with ST-segment elevation myocardial infarction treated with immediate percutaneous coronary intervention. Kardiol Pol 69:452-457
17. Maeller HS, Cohen LS, Braunwald E et al (1992) Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analysis of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II. Circulation 85:1254-1264
18. Weisz G, Cox DA, Garcia E et al (2005) Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited. Am Heart J 150:358-364
19. Goto K, Nikolsky E, Lansky AJ et al (2011) Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial). Am J Cardiol 108:1387-1394
20. Himbert D, Klutman M, Steg G et al (2005) Cigarette smoking and acute coronary syndromes: a multinational observational study. Int J Cardiol 100:109-117
21. Antman EM, Hand M, Armstrong PW et al (2008) 2007 focused Update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 117:296-329
22. Van de Werf F, Bax J, Betriu A, ESC Committee for Practice Guidelines (CPG) et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909-2945